Our findings that circulating levels of OPG were inversely associated with MRI activity, and the corresponding trends for sTNF-R1 and IL-1Ra, may suggest a beneficial effects of these cytokine modulators in MS, possibly mediated through their ability to block their corresponding pathogenic ligands. Here, TNFRSF11B is linked to myeloid sarcoma.